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Abstract
Background: Elevated levels of acute phase proteins (APP) are often found in patients with cardiovascular diseases. In a
previous study, we demonstrated the importance of the IL-6-gp130 axis -as a key regulator of inflammatory acute phase
signaling in hepatocytes-for the development of atherosclerosis.
Background/Principal Findings: Gp130-dependent gene expression was analyzed in a previously established hepatocyte-
specific gp130 knockout mouse model. We performed whole transcriptome analysis in isolated hepatocytes to measure
tissue specific responses after proinflammatory stimulus with IL-6 across different time points. Our analyses revealed an
unexpected small gene cluster that requires IL-6 stimulus for early activation. Several of the genes in this cluster are involved
in different cell defense mechanisms. Thus, stressors that trigger both general stress and inflammatory responses lead to
activation of a stereotypic innate cellular defense response. Furthermore, we identified a potential biomarker Lipocalin (LCN)
2 for the gp130 dependent early inflammatory response.
Conclusions/Significance: Our findings suggest a complex network of tightly linked genes involved in the early activation
of different parts of the innate immune response including acute phase proteins, complement and coagulation cascade.
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Introduction
Atherosclerosis is a major cause of cardiovascular disease
worldwide and characterized by artery wall thickening due to a
chronic inflammation in the intima of the arteries leading to
atherosclerotic plaque formation in the vessel wall [1],[2].
Unfortunately, strategies targeting key inflammatory mediators
had only limited success so far, highlighting the complex
pathogenesis of the disease. The inflammatory process in the
vessel wall is associated with enhanced levels of acute phase
proteins (APP), which are mainly expressed in the liver [3]. These
proteins are regarded as important components of the innate
immune response and powerful predictors of cardiovascular
incidences [4].
Although the acute phase response has been in focus of
investigation for many years [5], several aspects regarding the
functional implication of APP release in the process of chronic
inflammation are still not fully understood.
In an earlier study, we demonstrated the importance of the
gp130 cytokine receptor as a key regulator of acute phase signaling
is crucially involved in atherosclerotic plaque formation in a mouse
model of experimental atherosclerosis. Besides this important role
of the gp130 signal transducer, the cytokine IL-6 is widely
considered as the major inducer of APP production in mice
hepatocytes. Interestingly, IL-6 deficient mice exhibit only a partly
impaired APP production which suggests a redundant function for
the IL-6 cytokine family of cytokines which share the common
signalling receptor gp130 [5,6].
In order to better define the role of the IL-6 cytokines in the
gp130 knockout mouse model, we analyzed gp130 dependent gene
expression in isolated hepatocytes using a whole transcriptome
approach. Although local effects of gp130 dependent down-
regulation have been described [7], we aimed to study the
consequences of gp130-deficiency in our model system in a
broader context using a microarray time-course experiment.
Gp130-deficient hepatocytes cells were stimulated with IL-6 to
induce an inflammatory response. Changes in expression status
compared to IL-6-stimulated control cells from wild type mice
were measured for five consecutive time points (0 h, 1 h, 3 h, 6 h,
and 12 h). In contrast to resected liver tissue samples, this
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liver specific response after a proinflammatory stimulus.
While proinflammatory factors are considered key elements in
the pathogenesis of chronic inflammatory diseases, the underlying
mechanisms remain enigmatic [8]. Therefore, the goal of this
study was not only to target key inflammatory factors but also to
highlight correlated transcriptional responses to IL-6 treatment
which is in turn linked to chronic inflammation. A tight control of
the complex regulatory pathways is critical for immune homeo-
stasis and tissue specific gene expression. Growing evidence
highlighted the role of gp130-dependent gene expression in the
liver as critical for the regulation of the innate immune response. A
recent study demonstrated that the gp130 system controls innate
immune responses during infection by promoting myeloid-derived
suppressor cell function [9].
In this study, we report that a surprisingly small cluster of 8
gp130-dependent genes show a correlated transcriptional response
after IL-6 stimulation in hepatocytes. We identified differentially
expressed genes that play an important role as markers and
mediators of chronic inflammation. Co-expression network
analysis and pathway mapping revealed that these genes share a
functional role. The stimulatory IL-6 action overlaps with hepatic
acute-phase and innate immune responses. This might link the
gp130 system with the recruitment and activation of innate
immune cells as central players for inflammatory disorders
including cardiovascular diseases such as atherosclerosis.
Results
Correlated response of gp130-dependent genes
expression
In order to better define the role of the hepatic acute phase
response during inflammation and development of atherosclerosis
we used a hepatocyte-specific gp130 knockout model. Based on our
previous findings, we aimed to identify novel liver derived gp130
dependent factors in mice, which might play an essential role in
chronic inflammatory processes. Therefore, we performed tran-
scriptome-wide analysis of 26,766 genes by microarray time-course
analysisofisolated hepatocytes.Thetranscriptomeprofilingrevealed
a surprisingly small number of 38 genes that are differentially
expressed with a p-value of ,0.05 and .1.5 fold after IL-6
stimulation in at least one of the five time points (Table S1).
Instead offocusing on the analysis ofsingle differentially expressed
genes, we were interested in identifying a cluster of genes sharing a
coordinated response after IL-6 stimulation in the hepatocyte-
specific gp130 mouse model. Hierarchical clustering of the time
course expression data revealed that a group of 8 gp130 dependent
genes showed a coordinated early response to stimulation with IL-6
in hepatocytes. A heatmap diagram displays the group of genes that
are similarly regulated in Figure 1A. The group includes: (1) acute
phase proteins including saa3 and lcn2 (2) chemokines with cytokine-
cytokine interactions, such as cxcl1 and (3) extracellular matrix
proteins,suchastimp-1.Thecoordinated expressionpatternsofthese
gp130 dependent genes point to a common underlying mechanism
responsible for the early inflammatory response in IL-6 stimulated
hepatocytes. Of the genes that are subject to synergistic activation by
IL-6, the lcn2gene showed the moststriking potentiation. The results
of the microarray data for this group of genes were then further
confirmed by real-time PCR (Figure 1 B).
Validation of soluble proteins for the gp130 model of
atherosclerosis
Gene co-expression analysis provides powerful information to
identify new functionally related genes in a tissue specific context.
However, this expression relationship only reflects mRNA
transcripts but not protein levels. Therefore, we tested the soluble
gene products of the correlated cluster harboring 8 genes identified
through transcriptome profiling in hepatocyte supernatant to
measure differences in soluble protein levels.
Since LCN 2, CXLC2, TIMP-1, HAMP and IL-24 protein
expression is also induced to be released in the supernatant of
hepatocytes upon IL-6 stimulation in a gp130-dependent manner,
as confirmed by ELISA technique (Figure 2). Next we investigated
whether these 8 genes in hepatocytes and the related soluble
factors may be the onset of experimental atherosclerosis in a
mouse model. Therefore, we compared gp130–/apoE– mice
compared to apoE–mice fed a high-fat western type diet for 12
weeks. Accordingly mRNA expression was investigated within the
liver, and protein levels were analyzed in the plasma of these mice.
Significant differences in mRNA expression were observed for
saa3, lcn2, socs-3 and cxcl-1 genes, and differences in protein levels
were observed for cxcl1, timp-1 and lcn2 genes (Figure 3). CXCL1
mRNA expression was reduced in the liver of gp130–/apoE–mice
compared to apoE–mice, whereas plasma levels were significantly
increased. Thus it is tempting to speculate that other cells then
hepatocytes e.g. macrophages, neutrophils or epithelial cells [13]
are responsible for an increase of CXCL1 in the plasma. Of
interest, we observed a significant increase of TIMP-1 mRNA-
expression in the liver and in the plasma of gp130–/apoE– mice,
compared to apoE– mice. An IL-6 dependent TIMP-1 induction
was recently demonstrated in a hepatoma cell line [14]. Since we
investigated TIMP-1 expression in the whole liver, we cannot
exclude–that besides hepatocytes–other hepatic cells such as
endothelial cells and Kupffer cells which are minor cell
populations in the liver, also contribute to this effect.
Only LCN-2 was found to be reduced in the plasma of gp130–/
apoE– mice, which also showed the statistical strongest signs of
differential gene expression across all measured time points. For
the remaining candidate genes, only slight changes in protein
levels were observed in hepatocyte supernatants.
Pathway mapping
KEGG pathway mapping was used to search for over-
represented classes of gene functions for the identified 38 genes.
This was done by comparison of d.e genes for each time point with
canonical KEGG pathways using the hypergeometric distribution
function implemented in the statistical language R.
Over-represented pathways were detected for all time-points
after IL-6 stimulation. We could identify gp130-regulated genes,
which are associated with the activation of the JAK/STAT (socs-3,
Il-13ra1, cish, osmr, Il-24), and the cytokine signalling pathway (Il-
13ra1; osmr, cxcl1). Among both pathways, which play an important
role in the inflammatory response, 4 members of the co-expressed
cluster were found (socs3, cxcl1, Il-13ra1, cish). Table 1 displays the
pathways, according to the number of time points and
membership of d.e genes.
Co-expression network analysis
Conventional annotation methods measuring the over-repre-
sentation of functional categories, such as the performed KEGG-
pathway mapping may lack an adequate representation of
expression data in the functional specific cellular context. For this
reason, we performed a co-expression network analysis to reveal in
which functional cellular context the cluster with the 8 genes was
expressed.
Co-expression network analysis is based on the idea that large
collections of microarray data contain information about concert-
ed changes in transcript levels. Genes which share a functional role
Gp130-Dependent Signaling and Innate Immunity
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19427Figure 1. Co-expression analysis of gp130-regulated genes. (A) Time-course gene microarray analysis of hepatocytes for five different time
points before and after IL-6 stimulation (n.5 per group). Genes with .1.5 and ,21.5 fold change after IL-6 stimulation were clustered in a heatmap
diagram. Red indicates up-regulation compared with wild-type mice and green indicates down-regulation. (B) Quantitative real-time PCR of
hepatocytes taken from untreated (control), gp130–and wildtype (WT; gp130 flox) mice after time-dependent IL-6 stimulation. * P,0.05. Data are
presented as mean6SEM of at least 8 independent experiments.
doi:10.1371/journal.pone.0019427.g001
Figure 2. Analysis of gp-130 regulated soluble factors. CXLC1, LCN2, TIMP-1, HAMP and IL-24 concentration in the supernatant of IL-6
stimulated hepatocytes. Stimulation with IL-6 for 24 hours induces the release of CXCL1, LCN2, TIMP-1, HAMP and IL-24 within the supernatant of WT
(gp130 flox)-derived hepatocytes (CXCL1, LCN2, TIMP-1, HAMP and IL-24) or gp130–-derived hepatocytes (CXCL1, TIMP-1). CXCL1 was found to be
differentially regulated after 3 hours of IL-6 stimulation, LCN2 1, 6, 12 and 24 hours after IL-6 stimulation TIMP-1 and HAMP after 24 hours after IL-6
stimulation. Data are presented as mean6SEM of at least 4–5 independent experiments.
doi:10.1371/journal.pone.0019427.g002
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which in turn is driven by the same underlying regulatory factors.
In order to test the hypothesis that liver-derived gp130
dependent factors are involved in the same underlying molecular
network and to identify new functionally related genes, we used
co-expression data derived from a set of publicly available
microarray experiments in mice from the Coxpresdb database
[10]. In a first step, gp130-dependent genes were clustered based
on their relative expression patterns across different time-points.
Subsequently, a co-expression network was constructed for the
group of highly correlated candidate genes (information on how
co-expression networks are drawn: see Methods section).
The network analysis revealed that 7 of the 8 candidate genes
(highlighted in yellow in Figure 4) are part of a distinct co-
expression module. This co-expression module harbors genes
involved in different functional aspects of atherogenesis.
Several members of the co-expression module are annotated
with the KEGG classifications cytokine-cytokine interaction and
Toll-like receptor signaling. This is in line with the results from the
pathways analysis of overrepresented KEGG pathways for
differentially expressed genes. Among these genes are various
cytokines (cxcl1, cxcl2, Il-6, ccl2) and immune related genes (cd14,
myd88, nfkbiz), which play an important role in the pathogenesis of
atherosclerosis and as mediators of the inflammatory response.
Figure 3. Analysis of gp130-regulated genes and soluble factors in a mouse model of atherosclerosis. (A) Quantitative real-time PCR of
livers (n=4–6 per genotype) taken from gp130–/apoE– and apoE– mice following feeding a cholesterol rich diet for 12 weeks. Saa3, lcn2, socs3 and
cxcl1 mRNA-expression were significantly reduced in gp130-/apoE- mice compared to apoE-mice. (B) CXCL1, LCN2, TIMP-1, HAMP and IL-24 plasma
levels from gp130–/apoE– and apoE– mice following feeding a cholesterol rich diet for 12 weeks. CXCL1 and TIMP-1 plasma levels are significantly
increased in gp130–/apoE–- mice compared to apoE–mice, whereas LCN2 plasma levels are reduced within the same mice. IL-24 and HAMP plasma
levels did not differ between the genotypes. Data are presented as mean6SEM of at least 6–10 mice/genotype; *P,0.05 vs. control, #p,0.05 vs.
genotype.
doi:10.1371/journal.pone.0019427.g003
Table 1. KEGG pathways overrepresented by IL-6-gp130 gene expression.
Timepoint KEGG ID Pathway Input genes p-value
0h - - - -
1 h mmu04630 Jak-STAT signaling pathway Il-24, socs3 5.4610
24
3 h mmu04060 Cytokine-cytokine receptor interaction Il-24, Il13 ra1 6.5610
23
mmu04630 Jak-STAT signaling pathway Il-24, socs3, Il13ra1,cish 1610
25
6 h mmu04060 Cytokine-cytokine receptor interaction osmr, Il-24, Il-13 ra1 9.7610
24
mmu04630 Jak-STAT signaling pathway osmr ,Il-24, socs3, Il13 ra1, cish 1610
25
12 h mmu04060 Cytokine-cytokine receptor interaction osmr, Il-24, Il-13ra1, cxcl1 7610
25
mmu04630 Jak-STAT signaling pathway osmr, Il-24, socs3, Il13 ra1 1610
25
KEGG-database analysis revealed several gp130-regulated genes which are time-dependently associated with JAK/STAT (Il-24, socs3, Il-13ra1, cish, osmr) and cytokine
signalling pathway (Il-13ra1, Il-24, osmr, cxcl1).
doi:10.1371/journal.pone.0019427.t001
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cd14 which are prominent for mediating the innate immune
response [11,12].
Discussion
Transcriptome profiling revealed 38 gp130 dependent regulated
genes in response to IL-6 stimulation in hepatocytes. Within this
group of genes group we found a cluster of 8 genes which showed a
very specific correlated expression. Recently, an impaired acute
phase response in IL-6 deficient mice following IL-6 injection in
terms of the APPs haptoglobin, alpha 1-glycoprotein (orosomucoid
(ORM2)) and SAA was observed [15]. Thus, the question arises,
whether we could not detect haptoglobin or ORM2 to be
differentially regulated in our study. Our time course was 0–
12 hours, and these APPs were found to be differentially regulated
after 24 hours of IL-6 injection. Moreover, in our whole genome
microarray approach we also detected ORM2 and haptoglobin to
be differential regulated, but both APPs did not reach a
significance level of p,0.05. (ORM2 p=0.06 after 3 hours and
p=0.09 after 6 hours of IL-6 stimulation, haptoglobin p=0.05
after 12 hours of IL-6 stimulation). Additionally, Kopf et al used a
less parallel technique which might be more sensitive than our
microarray approach.
The combination of whole transcriptome profiling and co-
expression network analysis revealed that the identified genes are
not only highly correlated among themselves, but also involved in
the same co-expression module as key mediators and markers of
chronic inflammation. Besides well known markers of the acute
phase response, such as Il-6, cxcl1, stat3, saa3 or cd14, genes
involved in coagulation (plaur, serpine1) the complement system (hp,
c3) and extracellular matrix formation (timp-1, spp1) are found in
the same co-expression module with gp130-dependent genes.
These observations point to a link between different aspects of a
joint early inflammatory response after IL-6 stimulation in
hepatocytes (0 h–3 h). The small set of identified early response
genes are likely to share a common role in the same physiological
context. This is underlined by the pathway mapping, which
revealed a functional link between these genes to activation of the
Jak-STAT and cytokine-cytokine receptor KEGG pathways.
The IL-6/gp130 system has been shown to regulate a myriad of
genes involved in the early activation of innate immune signaling
Figure 4. Co-expression network for highly correlated gp130 dependent genes. The co-expression network is drawn based on gene
expression correlation patterns (Mutual rank scores) for the 8 candidate genes using the Coxpresdb tool [10]. A bold line indicates a high co-
expression between the genes. Orange lines indicate genes co-expressed in mouse and men. Red dotted lines indicate protein-protein interactions.
doi:10.1371/journal.pone.0019427.g004
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cascade and the gp130 system via cytokine interactions in
macrophages [17]. Furthermore, Sander et. al showed that IL-6,
which acts via gp130 is required for modulating the dynamics of
the innate immune cell recruitment during acute inflammation
[18]. The recruitment of innate immune cells plays a central role
in chronic inflammation and in the formation of atherosclerotic
plaques. A tight regulation of the innate immune cell activation is
necessary to prevent an overflowing immune response which
might lead to a chronic inflammatory state.
This interpretation is in line with the identification of a
prominent inflammatory marker expressed in liver and adipose
tissue. The adipokine LCN2 is central to cell defense, leads to
sustained chronic inflammation and protects aging mice from
insulin resistance [19],[20].
LCN2 was the only differentially regulated transcript measured
in every time point which also showed significantly lower levels for
soluble proteins. The functional role of this gene in the process of
atherosclerosis remains enigmatic. However, several studies have
shown a range of protective effects of LCN2. These include
various environmental perturbations such as chronic inflamma-
tion, insulin resistance and thermal stresses [21,22]. Of interest,
the study of Hemdahl et al. [23] shows that LCN2 is increased in
atherosclerosis and after myocardial infarction and colocalize with
MMP-9 in atherosclerotic lesions with high-proteolytic activity,
suggesting a modulating role for LCN2 in atherosclerosis. Further
studies are needed to investigate the role of LCN2 in atheroscle-
rosis in detail.
Taken together, these results suggest that multiple functional
innate immune related factors can strongly affect gene expression
in a gp130-dependent model of atherosclerosis. It seems likely that
a combination of these co-regulated factors is involved in the
complex interplay between the innate immune response and
chronic inflammation observed in this model. The small cluster of
8 genes is associated with different regulatory parts of the early
innate immune response. Dysregulation between these immune
signaling pathways in the liver might have crucial effects on
promoting atherosclerotic plaque formation via the recruitment of
immune cells. These observations are in line with a recent study on
hepatic acute-phase proteins in the gp130 model, promoting a
close relationship between hepatocytes and the activation of innate
immune cells [9].
In order to decipher this complex interplay between different
cellular immune signaling pathways, we need to further elucidate
phenotypic diversity caused by variations in the innate immune
response. Targeting gp130-dependent immune cell recruitment
might help to unravel the process of atherosclerotic plaque
formation. Furthermore, the functional role of LCN2 might give




Mice lacking the gp130 gene in the liver on an atherosclerosis-
prone background were generated as described previously [24]. In
brief, albumin promoter–controlled expression of the Cre
recombinase (alb-cre
tg) ensured a hepatocyte-specific deletion of
the floxed gp130 gene (gp130flox/flox). The resulting genotype,
alb-cre
tg; gp130
flox/flox is simplified by gp130–.Littermates with a
floxed gp130 gene (gp130
flox/flox) served as controls (simplified by
gp130 flox).
To obtain mice susceptible for atherosclerosis, these mice were
crossed with the atherosclerosis-prone apolipoprotein E (apoE)-
mice (simplified by gp130–/apoE–). Animals were backcrossed on
a C57BL/6 genetic background and housed in the animal facility
at the Hannover Medical School during experiments. All of the
experiments were approved by the governmental animal ethics
committee and performed according to the guidelines of the
Federation of European Animal Science Associations (03/683 and
14/39).
Cell culture
Hepatocytes from gp130– and gp130flox mice were isolated as
described previously [24]. Briefly, 10
6 cells were cultured on
collagen-coated 6 cm cell culture dishes (Nunc, Wiesbaden,
Germany) in DMEM (Invitrogen, Carlsbad, CA) containing
4.5 g/L glucose supplemented with 10% FCS and penicillin/
streptomycin for 24 hours. Cells were starved overnight and
stimulated with 200 ng/mL IL-6 for 0–24 hours under serum-free
conditions. Cell culture supernatants were collected and stored at
220uC.
ELISA
Concentrations of IL-6 dependent released factors within the
supernatant of hepatocytes were measured by ELISA (CXCL-1,
LCN2 and TIMP-1, R&D-Systems, IL-24 and HAMP, Ho ¨lzel
Diagnostik). In brief, supernatants of the hepatocytes were diluted
(1:10 for CXCL1-, LCS-2- and HAMP ELISA, 1:5 for TIMP-1)
or remain undiluted (IL-24), plasma samples from gp130–/apoE–
mice and apoE–mice fed with a cholesterol rich diet were diluted
(1:100 for CXCL1-, LCN-2- and HAMP ELISA, 1:10 for TIMP-
1, and 1:2 for IL-24 ELISA).
Microarray data analysis and real-time PCR
Hepatocytes RNA samples from at least 5 experimental groups
per time point were used for microarray analysis. RNA samples
were prepared and hybridized on Illumina Mouse genome
WG6V2 arrays. Gene expression levels were calculated using
GenomeStudio version 1.6.0 software (Illumina). Array data were
fit to a cubic spline normalization model in GenomeStudio, and
the expressed gene targets were identified using a detection level
$0.95. Differentially expressed genes were identified using the
Illumina custom error model. Genes with a corrected p-value
similar or ,0.05 and/or fold change .1.5 or less than 21.5 were
considered significantly regulated for each timepoint. Fold changes
of selected genes were visualized in a heat map diagram. All data
are MIAME compliant; Microarray data have been deposited in
the Gene Expression Omnibus under accession no. GSE25278.
Gene expression was validated by real time PCR. Total RNA
was isolated using TriFast-Reagent (peqLAB), and reverse
transcribed (Superscript reverse transcriptase; Invitrogen) with
oligo(dT) primers. Real time PCRs were performed in triplicates in
a total volume of 25 ml using brilliant SYBR green PCR master
mixture (Stratagene) on a 7300 Real-Time-PCR System (Applied
Biosystems) in 96-well PCR plates (Applied Biosystems). An initial
denaturation step at 95uC for 10 min was followed by 40 PCR
cycles, each cycle consisting of 95uC for 15 sec, 60uC for 1 min,
and 72uC for 1 min, and SYBR Green fluorescence emission was
monitored after each cycle. For normalization, expression of
GAPDH was determined in parallel as an endogenous control.
Relative gene expression was calculated using the 2-delta delta CT
method. Primer sequences for each gene are given in table 2.
KEGG-Pathway Mapping
Genes differentially expressed, as derived from pair-wise gene-
level comparison between time points, were selected for exploring
Gp130-Dependent Signaling and Innate Immunity
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genes. These included both up-and down-regulated genes.
Hypergeometric testing was performed on this collection of genes
to discover the over-represented KEGG pathways. This procedure
used Fisher’s exact test to find association between interesting
genes (differentially expressed between time points) and member-
ship to a KEGG pathway.
Data on co-expression networks
Data on gene co-expression was obtained from the COX-
PRESdb, a expression database for mammals (www.coxpresdb.
hgc.jp) [10]. The database contains a set of 2226 mice samples
from 154 experiments. All samples were selected from Affymetrix
Mouse Genome 430 2.0 Arrays and derived from NCBI’s Gene
Expression Omnibus (GEO) database (www.ncbi/nlm.nih.gov/
geo). The robust-multi-array average (RMA) method was used for
the normalization procedure of the raw expression data.
Pearson’s correlation coefficients were computed to measure
probe to probe expression patterns similarity for all possible gene
pairs. The co-expression networks are drawn based on mutual
rank information for the seven candidate genes. Dotted lines
indicate protein-protein interactions derived from the HPRD
database (www.hprd.org).
Statistical analysis
Data are presented as mean6SEM of at least 5–8 independent
experiments. For comparisons between three or more groups we
used 2-way ANOVA followed by the Holm-Sidak method for
multiple pair-wise comparisons. Differences were considered
statistically significant at a value of P,0.05.
Supporting Information
Table S1 Transcriptome-wide analysis of 26,766 genes
by microarray time-course analysis of isolated hepato-
cytes derived from gp130-mice and gp130flox used as
contols. Transcriptome profiling revealed a small number of 38
genes that are differentially expressed with a p-value of ,0.05 and
.1.5 fold after IL-6 stimulation in at least one of the five time
points. N=5 mice per genotype.
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